Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPC-201 Dose Titration in Alzheimer's Dementia
NCT02549196Phase 2Completed
- Sponsor
- Allergan
- Start
- Oct 2015
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil, solifenacin in Alzheimer's disease (AD), sponsored by Allergan. Started Oct 2015; status: completed.
02
Drugs
donepezilsolifenacin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02549196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549196.